Oxford Cannabinoid Technologies Holdings Yönetim
Yönetim kriter kontrolleri 1/4
Oxford Cannabinoid Technologies Holdings' CEO is Clarissa Sowemimo-Coker, appointed in Dec 2022, has a tenure of 1.5 years. total yearly compensation is £215.67K, comprised of 90% salary and 10% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth £2.87K. The average tenure of the management team and the board of directors is 1.5 years and 2.2 years respectively.
Anahtar bilgiler
Clarissa Sowemimo-Coker
İcra Kurulu Başkanı
UK£215.7k
Toplam tazminat
| CEO maaş yüzdesi | 90.0% |
| CEO görev süresi | 1.5yrs |
| CEO sahipliği | 0.2% |
| Yönetim ortalama görev süresi | 1.5yrs |
| Yönetim Kurulu ortalama görev süresi | 2.2yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Oct 31 2023 | n/a | n/a | -UK£4m |
| Jul 31 2023 | n/a | n/a | -UK£5m |
| Apr 30 2023 | UK£216k | UK£194k | -UK£6m |
| Apr 30 2022 | UK£194k | UK£174k | -UK£5m |
| May 31 2021 | n/a | n/a | -UK£3m |
Tazminat ve Piyasa: Clarissa's total compensation ($USD275.64K) is about average for companies of similar size in the UK market ($USD355.60K).
Tazminat ve Kazançlar: Clarissa's compensation has increased whilst the company is unprofitable.
CEO
Clarissa Sowemimo-Coker (44 yo)
1.5yrs
Görev süresi
UK£215,669
Tazminat
Ms. Clarissa Ann Sowemimo-Coker serves as Chief Executive Officer at Oxford Cannabinoid Technologies Holdings Plc since April 12, 2023 and is its Executive Director since February 4, 2021. She was its Comp...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Executive Director | 1.5yrs | UK£215.67k | 0.23% £ 2.9k | |
| Co-Founder & Non-Executive Director | no data | UK£25.00k | 1.96% £ 24.5k | |
| Finance Director & Executive Director | 1.7yrs | UK£155.16k | Veri yok | |
| Chief Scientific Officer | 3.9yrs | Veri yok | Veri yok | |
| General Counsel & Company Secretary | 1.5yrs | Veri yok | 0.030% £ 380.6 | |
| Executive Director & Chief Medical Officer | less than a year | Veri yok | Veri yok |
1.5yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim: OCTP's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Executive Director | 3.3yrs | UK£215.67k | 0.23% £ 2.9k | |
| Co-Founder & Non-Executive Director | 3.3yrs | UK£25.00k | 1.96% £ 24.5k | |
| Finance Director & Executive Director | 1.7yrs | UK£155.16k | Veri yok | |
| Executive Director & Chief Medical Officer | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Chair | 3.2yrs | UK£45.00k | 0.060% £ 747.5 | |
| Member of Scientific Advisory Board | 2.2yrs | Veri yok | Veri yok | |
| Senior Independent Non-Executive Director | 3.2yrs | UK£25.00k | Veri yok | |
| Member of Scientific Advisory Board | 2.2yrs | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | 2.2yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok |
2.2yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: OCTP's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.